<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
OR 15d-17 THEREUNDER
Capstone Pharmacy Services, Inc.
(Exact name of issuer as specified in charter)
2930 Washington Boulevard, Baltimore, Maryland 21230
(Address of principal executive offices)
Issuer's telephone number, including area code (410) 646-6987
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:
1. Title of security Common Stock
2. Number of shares outstanding before the change 15,836,565
3. Number of shares outstanding after the change 20,061,545
4. Effective date of change July 29, 1996
5. Method of change: Specify method (such as merger, acquisition, exchange,
distribution, stock split, acquisition of stock for treasury, etc.)
Private Offering
Give brief description of transaction Issuance in Acquisition and Private
Offering in connection therewith.
________________________________________________________________________________
II. CHANGE IN NAME OF ISSUER
1. Name prior to change ________________________________________________________
2. Name after change ___________________________________________________________
3. Effective date of charter amendment changing name ___________________________
4. Date of shareholder approval of change, if required _________________________
Date 8/7/96 /s/ Donald W. Hughes
--------------- ------------------------------
Donald W. Hughes
Vice-President, CFO, Secretary
and Treasurer
